RetinalGenix Technologies Inc. — Form D/A
RetinalGenix Technologies Inc. of APOLLO BEACH, FL, a company, filed a Form D amendment with the SEC on 2025-02-11. The offering totals $5.0M, of which $653K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2025-02-11
- Form: D/A
- Accession: 0001493152-25-005840
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $5.0M
- Amount sold: $653K
- Remaining: $4.3M
- Investors: 30
- Date of first sale: 2024-01-23
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-504938
Issuer
- Name: RetinalGenix Technologies Inc.
- CIK: 0001836295
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2017
- Address: 409 APOLLO BEACH BLVD, APOLLO BEACH, FL, 33572-2281
- Phone: (415) 578-9583
Officers, directors & promoters (5)
| Name | Role | Location |
|---|
| Herbert Gould | Director | Apollo Beach, FL |
| Jerry Katzman | Director | Apollo Beach, FL |
| Vinay Mehindru | Director | Apollo Beach, FL |
| Jerry Katzman | Executive Officer | Apollo Beach, FL |
| Virender Ahluwalia | Executive Officer | Petaluma, CA |
Other filings by this issuer (2)
More